Accessibility Menu
 
Orexo Ab (publ) logo

Orexo Ab (publ)

(OTC) ORXOY

Current Price$2.65
Market CapN/A
Since IPO (2013)-89%
5 Year-50%
1 Year+80%
1 Month+2%

Orexo Ab (publ) Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$385.57M

Net Income (TTM)

$129.89M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-0.14 (Low)

Price

$2.65

Volume

1

Open

$2.65

Previous Close

$2.65

Daily Range

$2.65 - $2.65

52-Week Range

$1.48 - $4.05

ORXOY News

No articles available.

ORXOY: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Orexo Ab (publ)

Industry

Pharmaceuticals

Headquarters

Uppsala, 751 05, SE

ORXOY Financials

Key Financial Metrics (TTM)

Gross Margin

-14%

Operating Margin

-40%

Net Income Margin

-34%

Return on Equity

0%

Return on Capital

-16%

Return on Assets

-10%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

0

Volume

1

Short Interest

0.00%

Avg. Volume

5.15

Financials (TTM)

Gross Profit

$55.36M

Operating Income

$346.03M

EBITDA

$285.18M

Operating Cash Flow

$172.57M

Capital Expenditure

$0.00

Free Cash Flow

$172.57M

Cash & ST Invst.

$910.11M

Total Debt

$490.97M

Orexo Ab (publ) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$3.29M

-97.9%

Gross Profit

$32.42M

-123.5%

Gross Margin

-9.85%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

110

N/A

Net Income

$44.19M

+62.0%

EBITDA

$69.82M

-312.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$419.15M

+218.8%

Accounts Receivable

$236.80M

-1.3%

Inventory

$0.00

-100.0%

Long Term Debt

$483.28M

+3.7%

Short Term Debt

$7.68M

-23.2%

Return on Assets

-9.96%

N/A

Return on Invested Capital

-15.54%

N/A

Free Cash Flow

$150.72M

+1224.8%

Operating Cash Flow

$150.72M

+1224.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AAWHAscend Wellness Holdings, Inc.
$0.49+1.46%
HLTRFHLS Therapeutics Inc.
$3.36+0.00%
JUSHFJushi Holdings Inc.
$0.48-5.74%
CBWTFAuxly Cannabis Group Inc.
$0.09-1.74%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$42.94-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.76+0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.15-0.06%
TLTiShares Trust - iShares 20+ Year Treasury Bond ETF
$85.81-0.02%

Questions About ORXOY

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.